Keywords
Last Name
Institution

LIGIA MARIA BELALCAZAR

TitleAdjunct Assistant Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
DivisionMedicine-Athero & Lipoproteins
Address6565 FANNIN STREET
HOUSTON TX 77030
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Pavela J, Suresh R, Blue RS, Mathers CH, Belalcazar LM. MANAGEMENT OF DIABETES DURING AIR TRAVEL: A SYSTEMATIC LITERATURE REVIEW OF CURRENT RECOMMENDATIONS AND THEIR SUPPORTING EVIDENCE. Endocr Pract. 2018 Feb; 24(2):205-219. PMID: 29466062.
      View in: PubMed
    2. Belalcazar LM, Ballantyne CM. Looking Back at Look AHEAD Through the Lens of Recent Diabetes Outcome Trials. Circulation. 2017 Feb 21; 135(8):720-723. PMID: 28223324.
      View in: PubMed
    3. Belalcazar LM, Papandonatos GD, Erar B, Peter I, Alkofide H, Balasubramanyam A, Brautbar A, Kahn SE, Knowler WC, Ballantyne CM, McCaffery JM, Huggins GS. Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD. Circ Cardiovasc Genet. 2016 Feb; 9(1):71-8. PMID: 26578543; PMCID: PMC4758870 [Available on 02/01/17].
    4. Belalcazar LM, Lang W, Haffner SM, Schwenke DC, Kriska A, Balasubramanyam A, Hoogeveen RC, Pi-Sunyer FX, Tracy RP, Ballantyne CM. Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEAD. Diabetes Care. 2015 Aug; 38(8):1544-50. PMID: 25972574.
      View in: PubMed
    5. Addison B, Belalcazar LM. Comment on Duran et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study. Diabetes Care 2014;37:2442-2450. Diabetes Care. 2015 Apr; 38(4):e67-8. PMID: 25805879.
      View in: PubMed
    6. Belalcazar LM, Papandonatos GD, McCaffery JM, Peter I, Pajewski NM, Erar B, Allred ND, Balasubramanyam A, Bowden DW, Brautbar A, Pi-Sunyer FX, Ballantyne CM, Huggins GS. A common variant in the CLDN7/ELP5 locus predicts adiponectin change with lifestyle intervention and improved fitness in obese individuals with diabetes. Physiol Genomics. 2015 Jun; 47(6):215-24. PMID: 25759378.
      View in: PubMed
    7. Belalcazar LM, Anderson AM, Lang W, Schwenke DC, Haffner SM, Yatsuya H, Rushing J, Vitolins MZ, Reeves R, Pi-Sunyer FX, Tracy RP, Ballantyne CM. Fiber intake and plasminogen activator inhibitor-1 in type 2 diabetes: Look AHEAD (Action for Health in Diabetes) trial findings at baseline and year 1. J Acad Nutr Diet. 2014 Nov; 114(11):1800-10.e2. PMID: 25131348; PMCID: PMC4253047.
    8. Peter I, Papandonatos GD, Belalcazar LM, Yang Y, Erar B, Jakicic JM, Unick JL, Balasubramanyam A, Lipkin EW, Delahanty LM, Wagenknecht LE, Wing RR, McCaffery JM, Huggins GS. Genetic modifiers of cardiorespiratory fitness response to lifestyle intervention. Med Sci Sports Exerc. 2014 Feb; 46(2):302-11. PMID: 23899896; PMCID: PMC4055466.
    9. Huggins GS, Papandonatos GD, Erar B, Belalcazar LM, Brautbar A, Ballantyne C, Kitabchi AE, Wagenknecht LE, Knowler WC, Pownall HJ, Wing RR, Peter I, McCaffery JM. Do genetic modifiers of high-density lipoprotein cholesterol and triglyceride levels also modify their response to a lifestyle intervention in the setting of obesity and type-2 diabetes mellitus?: The Action for Health in Diabetes (Look AHEAD) study. Circ Cardiovasc Genet. 2013 Aug; 6(4):391-9. PMID: 23861364; PMCID: PMC4077278.
    10. Thukunthla S, Belalcazar LM. Comment on: Cohen et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012;35:1420-1428. Diabetes Care. 2013 Jun; 36(6):e79. PMID: 23704687; PMCID: PMC3661791.
    11. Belalcazar LM, Haffner SM, Lang W, Hoogeveen RC, Rushing J, Schwenke DC, Tracy RP, Pi-Sunyer FX, Kriska AM, Ballantyne CM. Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study. Obesity (Silver Spring). 2013 May; 21(5):944-50. PMID: 23512860; PMCID: PMC3689862.
    12. Belalcazar LM, Lang W, Haffner SM, Hoogeveen RC, Pi-Sunyer FX, Schwenke DC, Balasubramanyam A, Tracy RP, Kriska AP, Ballantyne CM. Adiponectin and the mediation of HDL-cholesterol change with improved lifestyle: the Look AHEAD Study. J Lipid Res. 2012 Dec; 53(12):2726-33. PMID: 22956782; PMCID: PMC3494242.
    13. Hawkins M, Belalcazar LM, Schelbert KB, Richardson C, Ballantyne CM, Kriska A. The effect of various intensities of physical activity and chronic inflammation in men and women by diabetes status in a national sample. Diabetes Res Clin Pract. 2012 Jul; 97(1):e6-8. PMID: 22510300.
      View in: PubMed
    14. Belalcazar LM, Ballantyne CM. Nutrition and metabolism--sphingolipids and branched chain amino acids: indicators and effectors of adipose tissue function and diabetes risk. Curr Opin Lipidol. 2011 Dec; 22(6):503-4. PMID: 22101560.
      View in: PubMed
    15. Belalcazar LM, Ballantyne CM, Lang W, Haffner SM, Rushing J, Schwenke DC, Pi-Sunyer FX, Tracy RP. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study. Arterioscler Thromb Vasc Biol. 2011 Jul; 31(7):1689-95. PMID: 21512162; PMCID: PMC3130500.
    16. Clark MC, Nguyen H, Belalcazar LM. Evaluating if patient self-perceptions of competencies have an influence on biological indicators for cardio-metabolic health. Diabetes Res Clin Pract. 2011 Apr; 92(1):e3-6. PMID: 21227529.
      View in: PubMed
    17. Belalcazar LM, Reboussin DM, Haffner SM, Hoogeveen RC, Kriska AM, Schwenke DC, Tracy RP, Pi-Sunyer FX, Ballantyne CM. A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care. 2010 Nov; 33(11):2297-303. PMID: 20682679; PMCID: PMC2963483.
    18. Belalcazar LM, Reboussin DM, Haffner SM, Reeves RS, Schwenke DC, Hoogeveen RC, Pi-Sunyer FX, Ballantyne CM. Marine omega-3 fatty acid intake: associations with cardiometabolic risk and response to weight loss intervention in the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care. 2010 Jan; 33(1):197-9. PMID: 19841042; PMCID: PMC2797972.
    19. Belalcazar LM, Raghavan VA, Ballantyne CM. Statin-induced diabetes: will it change clinical practice? Diabetes Care. 2009 Oct; 32(10):1941-3. PMID: 19794006; PMCID: PMC2752927.
    20. Belalcazar LM, Swank PR. Translating the chronic care model into the community: results from a randomized controlled trial of a multifaceted diabetes care intervention: response to Piatt et al. Diabetes Care. 2006 Dec; 29(12):2761-2; author reply 2762. PMID: 17130227.
      View in: PubMed
    21. Oka K, Belalcazar LM, Dieker C, Nour EA, Nuno-Gonzalez P, Paul A, Cormier S, Shin JK, Finegold M, Chan L. Sustained phenotypic correction in a mouse model of hypoalphalipoproteinemia with a helper-dependent adenovirus vector. Gene Ther. 2007 Feb; 14(3):191-202. PMID: 16957769; PMCID: PMC1780075.
    22. Cowey SL, Quast M, Belalcazar LM, Wei J, Deng X, Given R, Singh P. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression. Cancer. 2005 Jun 15; 103(12):2643-53. PMID: 15864814.
      View in: PubMed
    23. Naoum JJ, Zhang S, Woodside KJ, Song W, Guo Q, Belalcazar LM, Hunter GC. Aortic eNOS expression and phosphorylation in Apo-E knockout mice: differing effects of rapamycin and simvastatin. Surgery. 2004 Aug; 136(2):323-8. PMID: 15300198.
      View in: PubMed
    24. Recinos A, Carr BK, Bartos DB, Boldogh I, Carmical JR, Belalcazar LM, Brasier AR. Liver gene expression associated with diet and lesion development in atherosclerosis-prone mice: induction of components of alternative complement pathway. Physiol Genomics. 2004 Sep 16; 19(1):131-42. PMID: 15238619.
      View in: PubMed
    25. Pastore L, Belalcazar LM, Oka K, Cela R, Lee B, Chan L, Beaudet AL. Helper-dependent adenoviral vector-mediated long-term expression of human apolipoprotein A-I reduces atherosclerosis in apo E-deficient mice. Gene. 2004 Mar 3; 327(2):153-60. PMID: 14980712.
      View in: PubMed
    26. Weinman SA, Belalcazar LM. Hepatitis C: a metabolic liver disease. Gastroenterology. 2004 Mar; 126(3):917-9. PMID: 14988846.
      View in: PubMed
    27. Belalcazar LM, Merched A, Carr B, Oka K, Chen KH, Pastore L, Beaudet A, Chan L. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation. 2003 Jun 3; 107(21):2726-32. PMID: 12742997.
      View in: PubMed
    28. Szymajda A, Eledrisi MS, Lieberman S, Belalcazar LM, Schnadig V. Visual vignette. Cushing's syndrome due to ectopic production of ACTH by a bronchial carcinoid. Endocr Pract. 2001 Nov-Dec; 7(6):492. PMID: 11770489.
      View in: PubMed
    29. Belalcazar LM, Ballantyne CM. Defining specific goals of therapy in treating dyslipidemia in the patient with low high-density lipoprotein cholesterol. Prog Cardiovasc Dis. 1998 Sep-Oct; 41(2):151-74. PMID: 9790415.
      View in: PubMed
    BELALCAZAR's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _